CRME Key Stats
|Revenue (Quarterly YoY Growth)||657.1%|
|EPS Diluted (TTM)||1.588|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||19.75M|
|Gross Profit Margin (Quarterly)||90.15%|
|Profit Margin (Quarterly)||-757.7%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM) Pro||Go Pro|
- Unusual 11 Mid-Day Movers 11/22: (ATRM) (PVG) (ARIA) Higher; (VMEM) (TFM) (DLIA) Lower Street Insider Nov 22
- 4 Healthcare Stock Stories Supporting Investment Wellness Nov 21
- Europace Publishes Data Supporting Use Of BRINAVESS™ (Vernakalant) As A First Line Agent For Pharmacological Cardioversion Of Atrial Fibrillation noodls Nov 21
- Cardiome's Brinavess shows positive results in cardiological publication Nov 21
- Cardiome To Acquire Correvio LLC noodls Nov 18
- Cardiome (CRME) to Acquire Correvio Street Insider Nov 18
- Cardiome Pharma CRME) trading halted with news pending Street Insider Nov 18
- Cardiome Pharma Management Discusses Q3 2013 Results - Earnings Call Transcript Seeking Alpha Nov 6
- Cardiome Reports Third Quarter 2013 Financial Results PR Newswire Nov 6
- Cardiome Announces Presentation At Medical Conference And Provides Update On Journal Publications For Vernakalant noodls Oct 28
CRME Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cardiome Pharma is up 346.8% over the last year vs S&P 500 Total Return up 29.82%, Osiris Therapeutics up 53.94%, and Cyclacel Pharmaceuticals down 22.92%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for CRME
Pro Strategies Featuring CRME
Did Cardiome Pharma make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Cardiome Pharma Corporation is a biopharmaceutical company which discovers, develops and commercializes new therapies that improve the health of patients around the world.